• 제목/요약/키워드: Second transplantation

검색결과 94건 처리시간 0.02초

Anti-tumor Efficacy of a Hepatocellular Carcinoma Vaccine Based on Dendritic Cells Combined with Tumor-derived Autophagosomes in Murine Models

  • Su, Shu;Zhou, Hao;Xue, Meng;Liu, Jing-Yu;Ding, Lei;Cao, Meng;Zhou, Zhen-Xian;Hu, Hong-Min;Wang, Li-Xin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권5호
    • /
    • pp.3109-3116
    • /
    • 2013
  • The majority of hepatocellular carcinoma (HCC) patients have a poor prognosis with current therapies, and new approaches are urgently needed. We have developed a novel therapeutic cancer vaccine platform based on tumor cell derived autophagosomes (DRibbles) for cancer immunotherapy. We here evaluated the effectiveness of DRibbles-pulsed dendritic cell (DC) immunization to induce anti-tumor immunity in BALB/c mouse HCC and humanized HCC mouse models generated by transplantation of human HCC cells (HepG2) into BALB/c-nu mice. DRibbles were enriched from H22 or BNL cells, BALB/c-derived HCC cell lines, by inducing autophagy and blocking protein degradation. DRibbles-pulsed DC immunization induced a specific T cell response against HCC and resulted in significant inhibition of tumor growth compared to mice treated with DCs alone. Antitumor efficacy of the DCs-DRibbles vaccine was also demonstrated in a humanized HCC mouse model. The results indicated that HCC/DRibbles-pulsed DCs immunotherapy might be useful for suppressing the growth of residual tumors after primary therapy of human HCC.

연소형 골수단구성 백혈병에서의 동종 조혈 모세포 이식 (Allogeneic Hematopoietic Stem Cell Transplantation in Juvenile Myelomonocytic Leukemia)

  • 유건희;유동길;이수현;성기웅;조은주;구홍회
    • Clinical and Experimental Pediatrics
    • /
    • 제48권2호
    • /
    • pp.178-185
    • /
    • 2005
  • 목 적 : JMML은 소아에서 발생하는 매우 드문 종류의 백혈병으로서 통상적인 항암화학요법만으로는 완치가 어려워 동종 조혈 모세포 이식을 시행하여야 한다. 아직 국내에서는 본 질환의 조혈 모세포 이식 성적에 대한 보고가 없어 저자들은 단일기관에서 경험한 JMML 환자의 동종 조혈 모세포 이식 성적을 보고하고자 하였다. 방 법 : 8개월에서 39개월 된 11명의 JMML 환자를 대상으로 동종 조혈 모세포 이식을 시행하였다. 조혈 모세포의 공급원으로 비혈연 골수 혹은 제대혈 7례, HLA 일치 형제 공여자 3례, HLA 1 항원 불일치 가족 공여자 1례 등을 이용하였다. 모든 환자들은 이식 전 항암화학요법을 시행 받았고 일부 환자에게는 13-cis-retinoic acid(CRA)를 사용하였다. 결 과 : 총 11례 중 3례만이 이식 전 치료로 혈액학적 및 임상적 완전관해에 도달하였다. 이식 후 1개월째 첫 키메리즘 평가 결과 완전 공여자 키메리즘 5례, 혼합 키메리즘 5례, 자가회복 1례였다. 혼합 키메리즘 상태에서 비장종대가 해소되지 않았던 1례에서 면역억제제의 급속 감량과 함께 CRA를 지속적으로 투여한 결과 완전 공여자 키메리즘으로의 전환과 함께 완전관해가 유도되었다. 자가회복 되었던 1례는 이식 후 조기 재발하였으나 복합 항암화학요법과 CRA의 투여로 이차 완전관해가 유도되었다. 결과적으로 11례 중 6례가 이식 후 정중 추적기간 15.5개월간 무사건 생존 중이다. 사망한 3례는 모두 완전 공여자 키메리즘에 실패하였던 경우들로서 질병의 재발 혹은 진행이 사망의 원인이었다. 결 론 : 본 연구 결과 JMML의 근치에는 동종 조혈 모세포 이식 후 이식편대 백혈병 효과가 중요한 역할을 담당하며 CRA도 긍정적 역할을 가지는 것으로 사료된다. 이식 후에도 완전관해에 도달하지 못하고 혼합 키메리즘 양상을 보이는 경우, 면역 억제제를 조기 감량하는 정책과 함께 CRA를 도입함으로써 완치의 가능성을 높일 수 있을 것으로 기대된다.

훼손예정지의 지형 및 수목 형태를 고려한 이식목 선정기준에 관한 연구 (Study on the Selection Criteria for Transplanting Trees in the Forest Reserve Areas Designated for Future Development)

  • 이수동;최송현
    • 한국환경생태학회지
    • /
    • 제23권6호
    • /
    • pp.535-544
    • /
    • 2009
  • 산지개발로 인해 불가피하게 훼손되어야 하는 양호한 식생을 대상으로 수목의 외형적 특성인 수형, 흉고직경 등과 기반특성인 토양층위 등 이식가능성 여부를 판단할 수 있는 기준을 제시하고자 본 연구를 진행하였다. 이식수목 선정은 자생성 및 천이단계에 의한 평가, 외형 및 기반특성에 의한 평가 2단계로 구분하여 진행하였다. 1단계에서는 식생발달 측면에서 천이를 주도하는 자생종이 아닌 인공식재수종과 생태적 천이 발달단계에서 도태가 예상되는 수목은 2단계 평가 전에 이식가능 수목에서 제외한 결과 총 3,841주 중 약 5.9%에 해당되는 수목이 이식 불가능한 것으로 판정되었다. 2단계 외형 및 기반특성에 따른 평가에서는 수형등급, 흉고직경급, 토양등급을 기준으로 각각의 수목을 평가한 결과 3,613주 중 약 33.7%(1,218주)는 이식 가능하였으나 23.0%(829주)는 이식 불가능한 것으로 분석되었다. 약 43.3%(1,566주)에 해당되는 수목에 대해서는 이식비용과 새롭게 식재하는 비용에 있어 큰 차이가 없으므로 가능한 이식하는 것이 생태계 보전 측면에서 바람직하나 토양상태 및 수형을 고려하여 현장 관리자의 의견을 반영하도록 제안하였다.

다른 면역 억제제에 듣지 않는 국소성 분절성 사구체 경화증 환자에서 Cyclosporin A 2차 치료에 의한 완해 경험 (Second Trial of Cyclosporin A-Induced Remission in Other Immunosuppressant Therapy-Resistant FSGS Patient)

  • 조희연;이범희;강주형;하일수;정해일;최용
    • Childhood Kidney Diseases
    • /
    • 제9권1호
    • /
    • pp.83-90
    • /
    • 2005
  • Focal segmental glomerulosclerosis(FSGS) has been detected in approximately 10% of cases of Idiopathic nephrotic syndrome in children, and exhibits a poor response to initial steroid therapy, as well as a higher rate of progression to chronic renal failure and relapse after kidney transplantation. We describe a case of an eleven year-old boy with steroid-resistant FSGS who exhibited a response to a second trial of cyclosporin h(CsA) therapy. At the age of 26 months, this patient was diagnosed with steroid-resistant FSGS. For 9 years, he had undergone a gauntlet of therapies to induce remission; oral steroids, cyclophosphamide, methylprednisolone(mehyIPd) pulse therapy, CsA, and ibuprofen therapy. Although these therapies failed to induce remission, the patient's renal function remained In the normal range during the nine years of treatment. At the age of ten years, the patient's proteinuria decreased, and complete remission was attained with a second administration of CsA, coupled with a low dose of oral steroids. This patient continues to receive CsA without relapse. Therefore, our major concern involves the possibility of relapse after the discontinuation of CsA therapy Our findings in this case suggest that, in cases of refractory FSGS, if renal insufficiency does not emerge, aggressive therapy for the amelioration of proteinuria should be continuously pursued.

  • PDF

Experimental Study on Inhibition Effects of the XAF1 Gene against Lung Cancer Cell Proliferation

  • Yang, Wen-Tao;Chen, Dong-Lai;Zhang, Fu-Quan;Xia, Ying-Chen;Zhu, Rong-Ying;Zhou, Duan-Shan;Chen, Yong-Bing
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권18호
    • /
    • pp.7825-7829
    • /
    • 2014
  • Objective: To investigate the effect of high expression of XAF1 in vivo or in vitro on lung cancer cell growth and apoptosis. Methods: 1. The A549 human lung cancer cell line was transfected with Ad5/F35 - XAF1, or Ad5/F35 - Null at the same multiplicity of infection (MOI); (hereinafter referred to as transient transfected cell strain); XAF1 gene mRNA and protein expression was detected by reverse transcription polymerase chain reaction (RT-PCR) and Western blotting respectively. 2. Methyl thiazolyl tetrazolium (MTT) and annexin V-FITC/PI double staining were used to detect cell proliferation and apoptosis before and after infection of Ad5/F35 - XAF1 with Western blotting for apoptosis related proteins, caspase 3, caspase - 8 and PARP. 3. After the XAF1 gene was transfected into lung cancer A549 cells by lentiviral vectors, and selected by screening with Blasticidin, reverse transcription polymerase chain reaction (RT-PCR) and Western blotting were applied to detect mRNA and protein expression, to establish a line with a stable high expression of XAF1 (hereinafter referred to as stable expression cell strain). Twenty nude mice were randomly divided into groups A and B, 10 in each group: A549/XAF1 stable expression cell strain was subcutaneously injected in group A, and A549/Ctrl stable cell line stable expression cell strain in group B (control group), to observe transplanted tumor growth in nude mice. Results: The mRNA and protein expression of XAF1 in A549 cells transfected by Ad5/F35 - XAF1 was significantly higher than in the control group. XAF1 mediated by adenovirus vector demonstrated a dose dependent inhibition of lung cancer cell proliferation and induction of apoptosis. This was accompanied by cleavage of caspase -3, -8, -9 and PARP, suggesting activation of intrinsic or extrinsic apoptotic pathways. A cell strain of lung cancer highly expressing XAF1 was established, and this demonstrated delayed tumor growth after transplantation in vivo. Conclusion: Adenovirus mediated XAF1 gene expression could inhibit proliferation and induce apoptosis in lung cancer cells in vitro; highly stable expression of XAF1 could also significantly inhibit the growth of transplanted tumors in nude mouse, with no obvious adverse reactions observed. Therefore, the XAF1 gene could become a new target for lung cancer treatment.

상악 구개측 매복 견치의 교정적 치료 (ORTHODONTIC TREATMENT OF PALATALLY IMPACTED GAMINE)

  • 장영일;손영화;김태우
    • 대한치과교정학회지
    • /
    • 제24권3호
    • /
    • pp.509-519
    • /
    • 1994
  • Upper canine is described as 'cornerstone' of maxilla, and its importance is implicated by long root and good alveolar support. The incidence of impaction of upper canine is the second most frequent next to the third molar because it takes a long period of time to develop, and has a complicated path of eruption, and erupts lately. Generally, the patient who has a palatally impacted canine visit the clinic primarily due to a missing of canine after 12-13 years old. Palatally impacted canine is different from labially impacted canine in its cause and treatment process. It is due to malposition or anomalous lateral incisor rather than arch length deficiency. Once the impaction is identified, the first stage of the treatment is to localiz the lesion by radiographic examinations or others and according to severity, orthodontic traction, or transplantation should be considered, and comprehensive diagnosis and treatment plan of malocclusion should be estsblished. Properly managed impacted canine can provide funtion and esthetic through proper diagnosis and treatment of extraction of canine is not indicated.

  • PDF

A Case of Successful Surgical Repair for Pectus Arcuatum Using Chondrosternoplasty

  • Kim, Sang Yoon;Park, Samina;Kim, Eung Rae;Park, In Kyu;Kim, Young Tae;Kang, Chang Hyun
    • Journal of Chest Surgery
    • /
    • 제49권3호
    • /
    • pp.214-217
    • /
    • 2016
  • Pectus arcuatum is a rare complex chest wall deformity. A 31-year-old female presented with a severely protruding upper sternum combined with a concave lower sternum. We planned a modified Ravitch-type operation. Through vertical mid-sternal incision, chondrectomies were performed from the second to fifth costal cartilages, saving the perichondrium. Horizontal osteotomy was performed in a wedge shape on the most protruding point, and followed by an additional partial osteotomy at the most concaved point. The harvested wedge-shape bone fragments were minced and re-implanted to the latter osteotomy site. The osteotomized sternum was fixed with multiple wirings. With chondrosternoplasty, a complex chest wall deformity can be corrected successfully.

$Regenaform^{(R)}$$Ossix^{(R)}$ 차단막을 이용한 골유도재생술: 증례보고 (GUIDED BONE REGENERATION USING $REGENAFORM^{(R)}\;AND\;OSSIX^{(R)}$ MEMBRANE: THREE CASE REPORTS)

  • 김영균;윤필영;임성철;김수관
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제33권6호
    • /
    • pp.648-653
    • /
    • 2007
  • This case study investigated the clinical effect of guided bone regeneration(GBR) using $Regenaform^{(R)}\;and\;Ossix^{(R)}$ membrane and the histology of the new bone that formed just under the membranes. $Regenaform^{(R)}$ transplantation and covering with $Ossix^{(R)}$ membrane were performed to repair bone defects around implants after implantation in three patients. After $3{\sim}4$ months, the membranes were removed in a second operation, and a biopsy was taken under the membrane. The biopsies showed a bone density of $23{\sim}42%$, and subsequent prosthetic treatments were successful in all cases.

Familial Juvenile Hyperuricemic Nephropathy 2례 (Two cases of Familial Juvenile Hyperuricemic Nephropathy)

  • 박진호;최보화;이소영;유은실;박영서
    • Childhood Kidney Diseases
    • /
    • 제1권2호
    • /
    • pp.183-188
    • /
    • 1997
  • Familial juvenile hyperuricemic nephropathy is an autosomal dominant disease characterized by progressive renal disease and hyperuricemia or gout, affecting young people of either sex equally. There are two biochemical markers of this disorder. The first is hyperuricemia disproportionate to the degree of renal dysfunction; the second is a grossly reduced clearance of uric acid relative to creatinine, dispropotionate to age, sex and degree of renal failure. We experienced 2 family members with hyperuricemia. One family member, a 13-year-old girl who had suffered from tophaceous gout and chronic renal failure. Her younger brother also had hyperuricemia and moderately reduced renal function. Their urinary excretion fractions of uric acid($FE_{uric\;acid}$) were reduced and renal biopsy specimens showed interstitial fibrosis with tubular atrophy and interstitial urate crystal deposition. We have treated these two patients with allopurinol but we have done renal transplantation because she progressed to end stage renal disease at 16 year old age.

  • PDF

Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology

  • Yoon, In Cheol;Eun, Jong Ryeol
    • Journal of Yeungnam Medical Science
    • /
    • 제36권2호
    • /
    • pp.67-77
    • /
    • 2019
  • The paradigm of chronic liver diseases has been shifting. Although hepatitis B and C viral infections are still the main causes of liver cirrhosis and hepatocellular carcinoma (HCC), the introduction of effective antiviral drugs may control or cure them in the near future. In contrast, the burden of nonalcoholic fatty liver disease (NAFLD) has been increasing for decades, and 25 to 30% of the general population in Korea is estimated to have NAFLD. Over 10% of NAFLD patients may have nonalcoholic steatohepatitis (NASH), a severe form of NAFLD. NASH can progress to cirrhosis and HCC. NASH is currently the second leading cause to be placed on the liver transplantation list in the United States. NAFLD is associated with obesity, type 2 diabetes, dyslipidemia, and metabolic syndrome. The pathophysiology is complex and associated with lipotoxicity, inflammatory cytokines, apoptosis, and insulin resistance. The only proven effective treatment is weight reduction by diet and exercise. However, this may not be effective for advanced fibrosis or cirrhosis. Therefore, effective drugs are urgently needed for treating these conditions. Unfortunately, no drugs have been approved for the treatment of NASH. Many pharmaceutical companies are trying to develop new drugs for the treatment of NASH. Some of them are in phase 2 or 3 clinical trials. Here, pharmacologic therapies in clinical trials, as well as the basic principles of drug therapy, will be reviewed, focusing on pathophysiology.